Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.06 USD | -3.15% | -12.01% | -27.00% |
Apr. 11 | Zentalis Pharmaceuticals, Inc. Announces Executive Changes | CI |
Apr. 11 | Zentalis Pharmaceuticals, Inc. Announces CFO Changes | CI |
Financials (USD)
Sales 2024 * | 7M | Sales 2025 * | 4.28M | Capitalization | 785M |
---|---|---|---|---|---|
Net income 2024 * | -270M | Net income 2025 * | -305M | EV / Sales 2024 * | 55.9 x |
Net cash position 2024 * | 394M | Net cash position 2025 * | 340M | EV / Sales 2025 * | 104 x |
P/E ratio 2024 * |
-3.04
x | P/E ratio 2025 * |
-2.93
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.73% |
Latest transcript on Zentalis Pharmaceuticals, Inc.
1 day | -3.15% | ||
1 week | -12.01% | ||
1 month | -29.82% | ||
3 months | -6.67% | ||
6 months | -32.40% | ||
Current year | -27.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Cam Gallagher
FOU | Founder | 54 | 14-12-22 |
Mark Lackner
CTO | Chief Tech/Sci/R&D Officer | 56 | 22-10-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam Gallagher
FOU | Founder | 54 | 14-12-22 |
Diana Hausman
CTO | Chief Tech/Sci/R&D Officer | 61 | 23-05-07 |
Karan Takhar
BRD | Director/Board Member | 32 | 17-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.07% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 11.06 | -3.15% | 758,326 |
24-04-29 | 11.42 | +3.25% | 514,305 |
24-04-26 | 11.06 | +0.68% | 474,113 |
24-04-25 | 10.98 | -6.67% | 1,077,726 |
24-04-24 | 11.77 | -6.36% | 854,473 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.00% | 785M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.37% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- ZNTL Stock